ST13, Hsp70 interacting protein pseudogene 2Genealiases: []
Q-omics provides the consensus-scored ST13P2 profile across patient tissues and cancer cell-line models. ST13P2 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, ST13P2 is differentially expressed in 4, with the highest sampling consensus in LUAD. Additionally, ST13P2 RNA expression shows 8,667 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight READ, LUAD, and THYM as cancer lineages where ST13P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ST13P2 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ST13P2 survival associations across molecular data types. ST13P2 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ST13P2 RNA expression–survival associations across cancer types. High ST13P2 expression shows unfavorable associations in OV, LIHC, ACC and STAD, but favorable associations in READ and KIRC. The READ Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify READ as the clearest survival context for ST13P2 RNA expression.
This table summarizes ST13P2 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in LUAD for RNA.
This table ranks reproducible tumor–normal expression differences for ST13P2. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ST13P2 shows lower tumor expression in LUAD, LUSC and BLCA and higher tumor expression in HNSC. The LUAD box plot shows higher ST13P2 RNA expression in normal versus tumor tissue (log2 FC = −0.223, t-test p < 0.001).
This table shows molecular features associated with ST13P2 in patient tissues and cancer cell lines. In patient samples, ST13P2 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
